STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
STAAR Surgical appointed David Bailey as Chief Commercial Officer, a role that puts him on the executive committee reporting to President and CEO Warren Foust. Bailey led STAAR as President and CEO from 2001 to 2008 and as President of International Operations through 2011, during which he raised more than $60 million, secured the 2005 FDA approval of the ICL, launched across Asia, and reacquired the Canon joint venture in Japan; by 2011 ICL revenues stood at approximately $32 million with international sales at 74% of the total.
Key figures
- Icls sold to date
- more than 4 million ICLs in over 85 countries
- Fda icl approval year
- 2005
- Icl revenue growth since
- more than tenfold
- Capital raised bailey tenure
- more than $60 million
- Icl revenue end of tenure 2011
- approximately $32 million
- International revenue share 2011
- 74%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.